KURIAKOSE EMIL (Chief Medical Officer) received a stock award from TERNS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/16/2026ACC: 0001892413-26-000004
Officer· Chief Medical Officer
Since Mar 2024
+168.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
168.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+56.25K
Price / share
—
Trade value
—
% of position
111.7%
1/14/2026
50.37K→106.61K
Total
Net shares
+56.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/14/2026 | A · Award | +56.25K | — | — | 111.7% | 50.37K | 106.61K |
| Total | +56.25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
112.50K shares
Shares
+112.50K
Strike price
37.18
Held after
112.50K
Exercisable
—
1/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock112.50K shares | 1/14/2026 | A · Award | +112.50K | 37.18 | — | 112.50K |